Search results
Local dad beats 'Glioblastoma' Stage 4 Brain Cancer twice
WXII-TV Winston-Salem· 6 days agoMay is Brain Tumor Awareness Month. According to BrainTumor.org, those diagnosed with Glioblastoma...
Father beats Stage 4 brain cancer for second time
WIFR Rockford· 3 days agoWINSTON-SALEM, N.C. (WXII) - May is Brain Tumor Awareness Month. According to BrainTumor.org, the five-year survival rate for those diagnosed ...
Scientists use new approach to disable brain cancer cells' ability to survive
Medical Xpress· 1 day agoUntil now, it was believed that cancer cells prioritized growth and rapid proliferation. If cancer cells are solely focused on reproducing at the fastest ...
Here’s what to know about innovative treatment Dr. Richard Scolyer used on his own deadly cancer: ‘A...
NY Post via Yahoo News· 5 days agoIn other cancers, like lung cancer, Weber noted, similar courses of neoadjuvant therapy have had...
New mechanisms underlying tumor variety in brain cancers discovered
Medical Xpress· 1 day agoHeimberger, MD, Ph.D., the Jean Malnati Miller Professor of Brain Tumor Research and vice chair for...
Earnings call: Plus Therapeutics reveals Q1 2024 financials, clinical progress By Investing.com
Investing.com· 5 days agoThe company highlighted the closing of a private placement financing, raising $19.25 million, and...
Glioblastoma Foundation(R) Announces the Establishment of Groundbreaking Genomic Testing & Research...
The Joplin Globe· 6 days agoGlioblastoma is the most aggressive and lethal form of brain cancer, with a median survival rate of just 12 to 18 ...
Virginia Tech researchers join together on cancer | Newswise
Newswise· 4 days agoMay is both Brain Tumor Awareness Month and National Cancer Research Month. Virginia Tech’s Fralin Biomedical Research Institute at VTC is dedicated to ...
My doctor told me I had dandruff but the lumps were cancer
Yahoo Life UK· 5 days agoIt’s where I met my consultant, Mr Morley, who gave me some fairly positive news – he told me the ...
Nanopharmaceutics and Northwestern University Announce Initiation of Phase I Adaptive Dose...
Morningstar· 7 days agoALACHUA, Fla. and CHICAGO, May 14, 2024 /PRNewswire/ -- Nanopharmaceutics, Inc. (OTC:TGRP), a clinical-stage pharmaceutical development company, announced the initiation of a Phase I clinical ...